Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV
- PMID: 15328129
- PMCID: PMC514738
- DOI: 10.1128/AAC.48.9.3570-3572.2004
Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV
Abstract
Fluoroquinolone-resistant isolates of Haemophilus influenzae, obtained from a long-term care facility, were examined for nucleotide sequence differences in the quinolone-resistance-determining regions of gyrA, gyrB, parC, and parE. Similarities among the resistant isolates, plus multiple differences with susceptible isolates, suggest clonal dissemination involving two resistant subclones.
Similar articles
-
In vitro antibacterial activities of new fluoroquinolones against clinical isolates of haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC.Chemotherapy. 2004 Dec;50(6):265-75. doi: 10.1159/000082624. Epub 2004 Dec 8. Chemotherapy. 2004. PMID: 15608441
-
Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.Antimicrob Agents Chemother. 2015 Jan;59(1):461-6. doi: 10.1128/AAC.04005-14. Epub 2014 Nov 10. Antimicrob Agents Chemother. 2015. PMID: 25385097 Free PMC article.
-
Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.Antimicrob Agents Chemother. 2005 Feb;49(2):488-92. doi: 10.1128/AAC.49.2.488-492.2005. Antimicrob Agents Chemother. 2005. PMID: 15673722 Free PMC article.
-
ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents.Expert Opin Ther Pat. 2019 Mar;29(3):171-180. doi: 10.1080/13543776.2019.1575362. Epub 2019 Feb 6. Expert Opin Ther Pat. 2019. PMID: 30686070 Review.
-
Besifloxacin: A Critical Review of Its Characteristics, Properties, and Analytical Methods.Crit Rev Anal Chem. 2018 Mar 4;48(2):132-142. doi: 10.1080/10408347.2018.1429885. Epub 2018 Feb 2. Crit Rev Anal Chem. 2018. PMID: 29345957 Review.
Cited by
-
Different modes of action of naphthyridones in gram-positive and gram-negative bacteria.Antimicrob Agents Chemother. 2006 Jan;50(1):385-7. doi: 10.1128/AAC.50.1.385-387.2006. Antimicrob Agents Chemother. 2006. PMID: 16377719 Free PMC article.
-
Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children.J Clin Microbiol. 2008 Jan;46(1):361-5. doi: 10.1128/JCM.01561-07. Epub 2007 Oct 31. J Clin Microbiol. 2008. PMID: 17977993 Free PMC article.
-
Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin.Antimicrob Agents Chemother. 2004 Nov;48(11):4460-2. doi: 10.1128/AAC.48.11.4460-4462.2004. Antimicrob Agents Chemother. 2004. PMID: 15504883 Free PMC article.
-
Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions.Antimicrob Agents Chemother. 2009 Oct;53(10):4225-30. doi: 10.1128/AAC.00192-09. Epub 2009 Aug 3. Antimicrob Agents Chemother. 2009. PMID: 19651910 Free PMC article.
-
Global fluoroquinolone resistance epidemiology and implictions for clinical use.Interdiscip Perspect Infect Dis. 2012;2012:976273. doi: 10.1155/2012/976273. Epub 2012 Oct 14. Interdiscip Perspect Infect Dis. 2012. PMID: 23097666 Free PMC article.
References
-
- Barriere, S., and J. Hindler. 1993. Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease. Ann. Pharmacother. 27:309-310. - PubMed
-
- Biedenbach, D., and R. Jones. 2003. Five-year analysis of Haemophilus influenza isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 46:55-61. - PubMed
-
- Bootsma, H., A. Troelstra, A. VanVeen-Rutgers, F. Mool, A. deNeeling, and B. Overbeek. 1997. Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from The Netherlands. J. Antimicrob. Chemother. 39:292-293. - PubMed
-
- Campos, J., F. Roman, M. Georgiou, C. Garcia, R. Gomez-Lus, R. Canton, H. Escobar, and F. Baquero. 1996. Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J. Infect. Dis. 174:1345-1347. - PubMed
-
- Chen, D. K., A. McGeer, J. C. deAzavedo, and D. E. Low. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:233-239. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical